CXCL9 and Alzheimer disease: We found a large or huge effect size in CXCL9 (RoM, 2.29, 95% CI, 1.57–3.32, p < 0.001; I2 = 25.8%; Fig. 3), with a 130% rise in AD when compared to MCI.